The Board received an update from the FDA regarding the recent fungal meningitis outbreak and the New England Compounding Center.  For more information you may visit the FDA website at: www.fda.gov.

  

The Board has been working with Oregon health officials to alert county health departments, hospitals, laboratories and pharmacies around the state, asking them to look for cases of fungal meningitis or stroke following injection of any medication into the epidural space. 

 

Additional information can be found on the Health Department’s website at: http://public.health.oregon.gov/DiseasesConditions/CommunicableDisease/HAI/Pages/FungalMeningitis.aspx.